Veristat Featured Articles

  1. Bayesian Study Designs In Early-Phase Oncology Trials 5/23/2025

    In response to insufficient traditional dose-escalation methods, regulatory initiatives like the FDA’s Project Optimus advocate for identifying optimal biological doses rather than relying solely on maximum tolerated doses (MTD).

  2. The Evolving Landscape Of Radiopharmaceuticals In Oncology Research 4/24/2025

    From selecting appropriate targeting molecules to optimizing dosing strategies and managing off-target effects, radiopharmaceutical development demands a tailored and strategic clinical approach.

  3. Why Team Integration Makes Or Breaks Marketing Applications 4/10/2025

    True team integration transcends basic collaboration, requiring the dismantling of barriers between sponsors and vendors, eliminating departmental silos, and cultivating mutual accountability.

  4. Multi-Regional Clinical Trials: The Latest Guidance From FDA 3/12/2025

    Conducting multi-regional clinical trials (MRCTs) is essential for accelerating oncology drug development and ensuring broader patient access. However, differences across regions can impact findings.

  5. The Strategic Backbone Of Marketing Application Success 3/12/2025

    Through proactive timeline management and strategic oversight, organizations can achieve their regulatory goals with confidence.

  6. Taking A Statistics-Driven Approach To Clinical Trial Planning 3/12/2025

    Clinical trials are inherently complex, and even well-structured studies may struggle to achieve statistical significance due to challenges in study design, patient selection, and data variability.

  7. Clinical Trials, Meet Adaptive Design 2/14/2024

    Learn about adaptive design (AD) trials that reduce clinical trial time and cost while enhancing patient safety by minimizing exposure to unsafe or ineffective treatments.

  8. Executing Patient-Focused Drug Development (PFDD) For Successful Clinical Development 11/2/2023

    Discover why the differences between individuals and diseases are crucial when crafting a clinical development program.

  9. Single-Arm Studies For Use As A Registrational Study In Oncology 9/1/2023

    Get a recap of what industry experts had to say about single-arm oncology registrational studies, success stories, and valuable lessons learned.

  10. Laying The Groundwork To Measure The Impact Of DCTs 3/27/2023

    Explore some of the key takeaways from the Tufts CSDD Roundtable on quantifying the value proposition of decentralized clinical trial deployments.